Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, revised the terms of its upcoming IPO on Thursday. The Waconia, MN-based company now plans to raise $11 million by offering 2.1 million shares at $5,...read more
Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, announced terms for its IPO on Thursday. The Waconia, MN-based company plans to raise $10 million by offering 1.1 million shares at $8.75, the last close of...read more
Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's (DNB) billion-dollar deal. All three IPOs upsized their deals and priced above the range. Commercial data analytics provider Dun & Bradstreet (DNB) raised...read more
Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, filed on Thursday with the SEC to raise up to $12 million in an initial public offering. The company is currently listed on the OTCQB (SNBP) and has a market cap...read more
Nano-cap oncology biotech Sun BioPharma slashes valuation by 48% ahead of $11 million Nasdaq uplisting
Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, revised the terms of its upcoming IPO on Thursday. The Waconia, MN-based company now plans to raise $11 million by offering 2.1 million shares at $5,...read more
Micro-cap oncology biotech Sun BioPharma sets terms for $10 million Nasdaq uplisting
Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, announced terms for its IPO on Thursday. The Waconia, MN-based company plans to raise $10 million by offering 1.1 million shares at $8.75, the last close of...read more
US IPO Weekly Recap: 3 IPOs close out the 2Q in shortened holiday week
Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's (DNB) billion-dollar deal. All three IPOs upsized their deals and priced above the range. Commercial data analytics provider Dun & Bradstreet (DNB) raised...read more
Micro-cap oncology biotech Sun BioPharma files for a $12 million Nasdaq uplisting
Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, filed on Thursday with the SEC to raise up to $12 million in an initial public offering. The company is currently listed on the OTCQB (SNBP) and has a market cap...read more